|Venture Round, 9/05 |
Brook Venture Partners
Bioscan, Inc. develops instrumentation for the detection, synthesis, and imaging of radio labeled compounds used in life science research, molecular imaging, pharmaceutical development, and nuclear medicine fields. It offers single photon emission computed tomography and positron emission tomography imaging systems for preclinical applications. The companyâ€™s molecular imaging products include in vivo preclinical imagers and small-animal environment systems. Its PET/nuclear medicine products comprise chemistry synthesizers, radiochemistry laboratory products, and FDG production lab products. The companyâ€™s life sciences products include analytical and quality-control instruments for chemical purity and quality-control testing of radiopharmaceuticals. Bioscan, Inc. was founded in 1980 and is based in Washington, District of Columbia with an additional office in Paris, France.